原发性肾小球基底膜相关肾病遗传背景与诊治

doi:10.12372/jcp.2022.22e1257

Abstract

Abstract:

Glomerular basement membrane (GBM) is an important component of the glomerular filtration barrier. Variations in various genes encoding GBM-related proteins may lead to structural and functional abnormalities in GBM, resulting in a variety of primary glomerular diseases, such as Alport syndrome and Pierson syndrome. Insufficient clinical understanding of GBM-related diseases can lead to misdiagnosis and underdiagnosis. In this article, we will elaborate on the genetic background of primary GBM and the progress of treatment of its related diseases to improve clinicians' understanding of these diseases.

Key words: glomerular basement membrane, genetic background, renal disease, child

KUANG Xinyu. Genetic background, diagnosis and treatment of glomerular basement membrane-associated kidney disease[J].Journal of Clinical Pediatrics, 2022, 40(12): 894-898.

Figures/Tables 1

References 28

[1]	Chew C, Lennon R. Basement membrane defects in genetic kidney diseases[J]. Front Pediatr, 2018, 6: 11. doi: 10.3389/fped.2018.00011 pmid: 29435440
[2]	Borza DB. Glomerular basement membrane heparan sulfate in health and disease: a regulator of local complement activation[J]. Matrix Biol, 2017, 57-58: 299-310.
[3]	Naylor RW, Morais MRPT, Lennon R. Complexities of the glomerular basement membrane[J]. Nat Rev Nephrol, 2021, 17(2): 112-127. doi: 10.1038/s41581-020-0329-y
[4]	Aumailley M. Laminins and interaction partners in the architecture of the basement membrane at the dermal-epidermal junction[J]. Exp Dermatol, 2021, 30(1): 17-24. doi: 10.1111/exd.14239 pmid: 33205478
[5]	Togawa H, Nakanishi K, Mukaiyama H, et al. First Japanese case of Pierson syndrome with mutations in LAMB2[J]. Pediatr Int, 2013, 55(2): 229-231. doi: 10.1111/j.1442-200X.2012.03629.x
[6]	Funk SD, Lin MH, Miner JH. Alport syndrome and Pierson syndrome: diseases of the glomerular basement membrane[J]. Matrix Biol, 2018, 71-72: 250-261.
[7]	Cosgrove D, Liu S. Collagen IV diseases: a focus on the glomerular basement membrane in Alport syndrome[J]. Matrix Biol, 2017, 57-58: 45-54.
[8]	Cummings CF, Pedchenko V, Brown KL, et al. Extra-cellular chloride signals collagen IV network assembly during basement membrane formation[J]. J Cell Biol, 2016, 213(4): 479-494. doi: 10.1083/jcb.201510065
[9]	Quinlan C, Rheault MN. Genetic basis of type IV collagen disorders of the kidney[J]. Clin J Am Soc Nephrol, 2021, 16(7): 1101-1109. doi: 10.2215/CJN.19171220
[10]	Kashtan CE, Ding J, Garosi G, et al. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group[J]. Kidney Int, 2018, 93(5): 1045-1051. doi: S0085-2538(18)30085-1 pmid: 29551517
[11]	Zhang JL, Richetti S, Ramezani T, et al. Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2[J]. Matrix Biol, 2022, 112: 132-154. doi: 10.1016/j.matbio.2022.08.009
[12]	Wnuk M, Anderegg MA, Graber WA, et al. Neuropilin1 regulates glomerular function and basement membrane composition through pericytes in the mouse kidney[J]. Kidney Int, 2017, 91(4): 868-879. doi: S0085-2538(16)30609-3 pmid: 27988210
[13]	Darbro BW, Mahajan VB, Gakhar L, et al. Mutations in extracellular matrix genes NID1 and LAMC1 cause autosomal dominant Dandy-Walker malformation and occipital cephaloceles[J]. Hum Mutat, 2013, 34(8): 1075-1079. doi: 10.1002/humu.22351
[14]	Lin PY, Hung JH, Hsu CK, et al. A novel pathogenic HSPG2 mutation in Schwartz-Jampel syndrome[J]. Front Neurol, 2021, 12: 632336. doi: 10.3389/fneur.2021.632336
[15]	Xia P, Xie F, Zhou ZJ, et al. Novel LG1 mutations in agrin causing congenital myasthenia syndrome[J]. Intern Med, 2022, 61(6): 887-890. doi: 10.2169/internalmedicine.7774-21
[16]	Chen Z, Migeon T, Verpont MC, et al. HANAC syndrome Col4a1 mutation causes neonate glomerular hyperpermeability and adult glomerulocystic kidney disease[J]. J Am Soc Nephrol, 2016, 27(4): 1042-1054. doi: 10.1681/ASN.2014121217
[17]	Savige J, Harraka P. Pathogenic LAMA5 variants and kidney disease[J]. Kidney360, 2021, 2(12): 1876-1879. doi: 10.34067/KID.0007312021
[18]	Nozu K, Nakanishi K, Abe Y, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome[J]. Clin Exp Nephrol, 2019, 23(2): 158-168. doi: 10.1007/s10157-018-1629-4 pmid: 30128941
[19]	Shan LD, Peng J, Xiao H, et al. Clinical features and COL4A1 genotype of a toddler with hereditary angiopathy with nephropathy, aneurysms and muscle cramps syndrome[J]. Zhongguo Dang Dai Er Ke Za Zhi, 2019, 21(8): 754-760.
[20]	Kulali F, Calkavur S, Basaran C, et al. A new mutation associated with Pierson syndrome[J]. Arch Argent Pediatr, 2020, 118(3): e288-e291.
[21]	Kamiyoshi N, Nozu K, Fu XJ, et al. Genetic, clinical, and pathologic backgrounds of patients with autosomal dominant Alport syndrome[J]. Clin J Am Soc Nephrol, 2016, 11(8): 1441-1449. doi: 10.2215/CJN.01000116
[22]	Savige J, Lipska-Zietkiewicz BS, Watson E, et al. Guidelines for genetic testing and management of Alport syndrome[J]. Clin J Am Soc Nephrol, 2022, 17(1): 143-154. doi: 10.2215/CJN.04230321
[23]	Kashtan CE. Alport syndrome: achieving early diagnosis and treatment[J]. Am J Kidney Dis, 2021, 77(2): 272-279. doi: 10.1053/j.ajkd.2020.03.026 pmid: 32712016
[24]	Kashtan CE, Gross O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020[J]. Pediatr Nephrol, 2021, 36(3): 711-719. doi: 10.1007/s00467-020-04819-6 pmid: 33159213
[25]	Warady BA, Agarwal R, Bangalore S, et al. Alport syndrome classification and management[J]. Kidney Med, 2020, 2(5): 639-649. doi: 10.1016/j.xkme.2020.05.014
[26]	Torra R, Furlano M. New therapeutic options for Alport syndrome[J]. Nephrol Dial Transplant, 2019, 34(8): 1272-1279. doi: 10.1093/ndt/gfz131
[27]	Yamamura T, Horinouchi T, Adachi T, et al. Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5[J]. Nat Commun, 2020, 11(1): 2777. doi: 10.1038/s41467-020-16605-x
[28]	Lin MH, Miller JB, Kikkawa Y, et al. Laminin-521 Protein therapy for glomerular basement membrane and podocyte abnormalities in a model of pierson syndrome[J]. J Am Soc Nephrol, 2018, 29(5): 1426-1436. doi: 10.1681/ASN.2017060690

GBM定位	致病基因	疾病	遗传方式	临床表型	进展至ESRD风险
Ⅳ型胶原蛋白	COL4A1^[16]	HANAC 综合征	常染色体显性	脑、眼、肌肉、肾脏（血尿、轻度蛋白尿、肾囊肿、肾衰竭）	成人后进入ESRD
Ⅳ型胶原蛋白	COL4A3/4/5/6^[10]	Alport综合征	常染色体/X连锁显性/双基因	肾脏（血尿、蛋白尿、进行性肾功能下降）、眼、耳	XLAS男性、ARAS、COL4A5/COL4A3或A4男性、COL4A3/4反式排列者100%进入ESRD
层粘连蛋白	LAMB2^[5]	PIERS/NS	常染色体隐性	脑、眼、肾脏（蛋白尿、镜下血尿、肾功能异常）/肾外表现少	婴儿期进展至ESRD/不足1/3患者婴幼儿期进展至ESRD
层粘连蛋白	LAMA5^[17]	原发性NS/激素耐药性肾病综合征	常染色体隐性	眼、骨骼、肌肉、呼吸道、肾脏（囊肿、蛋白尿、肾发育不良）	肾功能基本正常，个例报道进展至ESRD
巢蛋白	NID1^[13]	ADDWOC	常染色体显性	脑、头皮、癫痫，无肾脏表型报道	-
硫酸肝素蛋白多糖	AGRN ^[15]	先天性肌无力综合征	常染色体隐性	骨骼肌，无肾脏表型报道	-
硫酸肝素蛋白多糖	HSPG2^[14]	Schwartz-Jampel综合征1型	常染色体隐性	骨骼、肌肉、眼、耳、智力、睾丸，无肾脏表型报道	-

Genetic background, diagnosis and treatment of glomerular basement membrane-associated kidney disease

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 28

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[9]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[10]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[11]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[12]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[13]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[14]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[15]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.